Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent

See also
Status	Clinical Trial	Phase
Completed	`NCT05053828` - Type 2 Diabetes With Antiplatelet Drugs
Not yet recruiting	`NCT03103685` - Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.	Phase 4
Completed	`NCT03989557` - Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms	Phase 4

See also

Status

Clinical Trial

Phase

Completed

NCT05053828 - Type 2 Diabetes With Antiplatelet Drugs

Not yet recruiting

NCT03103685 - Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Phase 4

Completed

NCT03989557 - Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02797548
Study type	Interventional
Source	Asan Medical Center
Contact	Jung-Hee Ham, RN, Project leader
Phone	+82230104728
Email	cvcrc5@amc.seoul.kr
Status	Recruiting
Phase	Phase 4
Start date	March 16, 2017
Completion date	December 31, 2024

Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery — ASSURE-DES

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms